Assignee
RESTEM LLC
US·3 granted patents·3 pending applications·0 citations·filing 2015–2024
Top patents by PatentIndex Score
6 records- 0166US11446329B2Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBSRESTEM LLC·Filed 2018·Granted Sep 20, 2022·0 cites·17 claims
- 0262US2023018682A1Methods and compositions of natural killer cell adoptive transfer therapyRESTEM LLC·Filed 2022·Application pending·0 cites
- 0359US12460179B2Lyophilized compositions containing umbilical cord lining stem cells conditioned mediumRESTEM LLC·Filed 2021·Granted Nov 4, 2025·0 cites·6 claims
- 0459US2025230404A1Method of using factor rich product from umbilical cord mesenchymal stem cells to increase collagen and elastin in human skinRESTEM LLC·Filed 2024·Application pending·0 cites
- 0553US2021355437A1Factor rich product from umbilical cord mesenchymal stem cellsRESTEM LLC·Filed 2021·Application pending·0 cites
- 0649US10760054B2Natural killer cells and methods for enhancing viability, proliferation and cytotoxicity of same following cryopreservationRESTEM LLC·Filed 2015·Granted Sep 1, 2020·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when RESTEM LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →